Abstract:The treatment of ischemic stroke (IS) remains a big challenge in clinics, and it is urgently needed to develop novel, safe, and effective medicines against IS. Here, we report the design, synthesis, and biological evaluation of organic NO2– donors as potential agents for the treatment of IS. The representative compound 4a was able to slowly generate low concentrations of NO2– by reaction with a thiol-containing nucleophile, and the NO2– was selectively converted into NO under ischemic/hypoxia conditions to protect primary rat neurons from oxygen–glucose deprivation and recovery (OGD/R)-induced cytotoxicity by enhancing the Nrf2 signaling and activating the NO/cGMP/PKG pathway. Treatment with 4a at 2 h before or after ischemia mitigated the ischemia/reperfusion-induced brain injury in middle cerebral artery occlusion (MCAO) rats by producing NO and enhancing Nrf2 signaling. Furthermore, 4a significantly promoted endothelial cell proliferation and angiogenesis within the ischemic penumbra. Our findings suggest that this type of NO2– donors, like 4a, may be valuable to fight IS and other ischemic diseases.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00282.The stability of 4a in different conditions; reaction kinetics of 4a and GSH; the pharmacokinetic behavior of 4a (including concentration–time curve and calculated pharmacokinetic parameters); the effects of 4a on enhancing Nrf2 signaling and activating the sGC/cGMP/PKG pathway in OGD/R rat primary cortical neurons, on blood pressure in rats, on enhancing the Nrf2 pathway in MCAO rats, and on the angiogenesis in vitro; the primers used in the real-time quantitative PCR; the HPLC analytical parameters of plasma NO2– levels and a representative chromatogram; HRMS spectra of the intermediates formed by the reaction of 4a with thiols; the 1H NMR, 13C NMR, and HRMS spectra for compounds 4a, 4c, and 4d; and the HPLC traces for the purity of compounds 4a–d (PDF)Molecular formula strings for compounds 4a–d (CSV)This article has not yet been cited by other publications.

Novel 2,6-Disubstituted Benzofuran-3-one Analogues Improve Cerebral Ischemia/reperfusion Injury Via Neuroprotective and Antioxidative Effects.

Novel Hybrids of 6-Amino-3-n-butylphthalide and Neuroprotective Groups against Ischemic Stroke

Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment

Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke

Design, Synthesis, and Biological Evaluation of Novel Cinnamide Derivatives as Neuroprotective Agents for the Treatment of Cerebral Ischemia

Design, synthesis, and evaluation of n-butylphthalide and ligustrazine hybrids as potent neuroprotective agents for the treatment of ischemic stroke in vitro and in vivo

LC-MS/MS metabolomic profiling of the protective butylphthalide effect in cerebral ischemia/reperfusion mice.

Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential Nrf2 activators for the treatment of cerebral ischemic injury

Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke

Synthesis and biological evaluation of 1,2,4-oxadiazole core derivatives as potential neuroprotectants against acute ischemic stroke

Synthesis, antioxidant and neuroprotective analysis of diversely functionalized α-aryl- N -alkyl nitrones as potential agents for ischemic stroke therapy

Discovery of 1,2,4-triazole derivatives as novel neuroprotectants against cerebral ischemic injury by activating antioxidant response element

Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents

Design, synthesis and biological evaluation of N-salicyloyl tryptamine derivatives as multifunctional neuroprotectants for the treatment of ischemic stroke

Design, Synthesis, and Biological Evaluation of Organic Nitrite (NO 2 – ) Donors as Potential Anticerebral Ischemia Agents

Dl-3-N-butylphthalide Attenuates Ischemic Reperfusion Injury by Improving the Function of Cerebral Artery and Circulation

Biopharmaceutical, preclinical pharmacokinetic and pharmaco-dynamic investigations of an orally administered novel 3-nbutylphthalide prodrug for ischemic stroke treatment

Development of Novel N-hydroxypyridone Derivatives As Potential Anti-Ischemic Stroke Agents

Discovery of phenylcarbamoyl xanthone derivatives as potent neuroprotective agents for treating ischemic stroke

Synthesis of Novel 3-Butylphthalide Derivatives Containing Isopentenylphenol Moiety as Potential Antiplatelet Agents for the Treatment of Ischemic Stroke

2-(-2-Benzofuranyl)-2-imidazoline Induces Bcl-2 Expression and Provides Neuroprotection Against Transient Cerebral Ischemia in Rats